A regulatory science push in the UK includes centres for digital transformation, AI and more.

Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards.

Early work from Scripps researchers uses a virtual library to synthesize plant-based metabolites: picrotoxanes.

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

Study investigates why vial choices matters for frozen biopharmaceutical storage.

Senate committee votes in favor of the nomination; full Senate vote will be next.

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

The Trump administration’s move to pause federal funding while projects are vetted causes concern and lawsuits

Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe.